Literature DB >> 21411803

Integration of a clinical pharmacist into the hematology-oncology clinics at an academic medical center.

John M Valgus1, Aimee Faso, Kelly M Gregory, Sandra Jarr, Scott Savage, Stephen Caiola, Christine M Walko, Jiyeun Kim, Stephen A Bernard.   

Abstract

PURPOSE: The development, implementation, and early experience with a program providing clinical pharmacist services at the hematology-oncology clinics of a university teaching hospital are described.
SUMMARY: With funding from a university research grant and other sources, a pharmacist was hired to launch a new program addressing four goals identified in a needs assessment: (1) improved management of supportive care, (2) enhanced education of patients receiving complicated chemotherapy regimens, (3) improved efficiency in the chemotherapy infusion unit, and (4) development of an experiential learning opportunity for pharmacy students and residents. The pharmacist hired to lead the ongoing program was a state-approved clinical pharmacist practitioner (CPP) who had authority to prescribe with physician oversight under established protocols. EXPERIENCE: An oncology supportive care consultation service implemented by the CPP in collaboration with a nurse and a physician served 89 new patients in its first 18 months of operation; during that period the CPP made 186 interventions and wrote 136 prescriptions. The CPP also established a chemotherapy counseling service that provided more than 900 bill-able patient education sessions over 18 months. In addition, the CPP launched an effort to increase use of a rituximab rapid-infusion protocol among eligible patients. The creation of the new oncology pharmacist position has given dozens of pharmacy students and residents a new opportunity for interaction with oncology clinic patients and other health care team members.
CONCLUSION: Integration of the services of a CPP into the hematology-oncology clinics has helped achieve goals set by physician, nursing, and pharmacy leaders.

Entities:  

Mesh:

Year:  2011        PMID: 21411803     DOI: 10.2146/ajhp100414

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

2.  Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center.

Authors:  Haitham W Tuffaha; Ola Abdelhadi; Suha Al Omar
Journal:  Int J Clin Pharm       Date:  2011-12-30

Review 3.  Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.

Authors:  Julianna A Merten; Jamie F Shapiro; Alison M Gulbis; Kamakshi V Rao; Joseph Bubalo; Scott Lanum; Ashley Morris Engemann; Sepideh Shayani; Casey Williams; Helen Leather; Tracey Walsh-Chocolaad
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-15       Impact factor: 5.742

4.  Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic.

Authors:  Ruth Chieng; John Coutsouvelis; Susan Poole; Michael J Dooley; Diana Booth; Andrew Wei
Journal:  Support Care Cancer       Date:  2013-08-21       Impact factor: 3.603

5.  Preferred information sources and needs of cancer patients on disease symptoms and management: a cross-sectional study.

Authors:  Abebe Basazn Mekuria; Daniel Asfaw Erku; Sewunet Admasu Belachew
Journal:  Patient Prefer Adherence       Date:  2016-09-29       Impact factor: 2.711

6.  The Expanding Role of the Oncology Pharmacist.

Authors:  Lisa M Holle; Eve M Segal; Kate D Jeffers
Journal:  Pharmacy (Basel)       Date:  2020-07-25

Review 7.  Pharmacist-managed clinics for patient education and counseling in Japan: current status and future perspectives.

Authors:  Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  J Pharm Health Care Sci       Date:  2015-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.